| Literature DB >> 30993986 |
Michael T Peruzzi1, Fabrice Gallou2, Stephen J Lee3, Michel R Gagné1.
Abstract
Site selective amide reductions of the cyclic undecapeptide, cyclosporine A, have been developed using the combination of a heteroleptic borane catalyst and a silane reductant. Tertiary silane Me2EtSiH provides two unique cyclosporine A derivatives, one of which can be readily diversified in subsequent reactions. The secondary silane Et2SiH2 enables divergent reactivity that uses a free hydroxyl group to direct the reduction. The transient O-silyl hemiaminal intermediate of this reduction can additionally be trapped by reducing to the amine or by reductive cyanation.Entities:
Mesh:
Substances:
Year: 2019 PMID: 30993986 PMCID: PMC7328826 DOI: 10.1021/acs.orglett.9b01245
Source DB: PubMed Journal: Org Lett ISSN: 1523-7052 Impact factor: 6.005